Fulgent Genetics (MEX:FLGT) EV-to-EBIT : -4.71 (As of Jun. 22, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Fulgent Genetics's Enterprise Value is MXN5,754 Mil. Fulgent Genetics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was MXN-1,222 Mil. Therefore, Fulgent Genetics's EV-to-EBIT for today is -4.71.

The historical rank and industry rank for Fulgent Genetics's EV-to-EBIT or its related term are showing as below:

MEX:FLGT' s EV-to-EBIT Range Over the Past 10 Years
Min: -817.49 Med: -4.28 Max: 592.59
Current: -4.32

During the past 10 years, the highest EV-to-EBIT of Fulgent Genetics was 592.59. The lowest was -817.49. And the median was -4.28.

MEX:FLGT's EV-to-EBIT is ranked worse than
100% of 100 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.415 vs MEX:FLGT: -4.32

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Fulgent Genetics's Enterprise Value for the quarter that ended in Mar. 2024 was MXN7,108 Mil. Fulgent Genetics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was MXN-1,222 Mil. Fulgent Genetics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -17.19%.

Fulgent Genetics EV-to-EBIT Historical Data

The historical data trend for Fulgent Genetics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics EV-to-EBIT Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-587.70

4.08

3.86

2.16

-5.92

Fulgent Genetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															-9.89	-8.14	-4.22	-5.92	-4.87

Competitive Comparison of Fulgent Genetics's EV-to-EBIT

For the Diagnostics & Research subindustry, Fulgent Genetics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fulgent Genetics's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's EV-to-EBIT falls into.

Fulgent Genetics EV-to-EBIT Calculation

Fulgent Genetics's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	5753.785	/	-1221.736
	=	-4.71

Fulgent Genetics's current Enterprise Value is MXN5,754 Mil.
Fulgent Genetics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-1,222 Mil.

Fulgent Genetics (MEX:FLGT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Fulgent Genetics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	-1221.736	/	7108.326
	=	-17.19 %

Fulgent Genetics's Enterprise Value for the quarter that ended in Mar. 2024 was MXN7,108 Mil.
Fulgent Genetics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-1,222 Mil.

Fulgent Genetics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics (MEX:FLGT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.